Allen L V, Stiles M L
Clin Toxicol. 1981 Sep;18(9):1043-65. doi: 10.3109/15563658108990335.
A investigation was conducted to determine the specificity of the EMIT DAU method of drugs of abuse analysis. Drug-free urine, from healthy volunteers, was individually spiked at 1000, 100, 10, and 1 microgram/mL concentrations with each of 162 different drug substances. These spiked samples were analyzed with the EMIT DAU assay for amphetamines, barbiturates, benzodiazepine metabolites, cocaine metabolites, methadone, opiates, and propoxyphene. Although several of the test methods yielded positive results at a concentration of 100 micrograms/mL, many drugs will probably not reach that concentration in the urine. The number of drugs giving a false positive at a concentration of 100 micrograms/mL was very low. The assay for cocaine metabolites gave no false positive results at any of the concentrations studied while the assay for methadone gave the largest number of false positive results. When interpreting the results of this investigation one must consider that in many cases drug metabolites will exist in the urine, salt forms of the drugs studied were used, and ionic strength and pH effects can interfere with the lysozyme enzyme system used in the EMIT DAU assays. In summary, the proper utilization of specificity information may assist the analyst in explaining unusual values obtained in the laboratory, particularly when the subject is concurrently using prescription or nonprescription medication.
开展了一项调查以确定用于滥用药物分析的酶倍增免疫测定法(EMIT DAU)的特异性。从健康志愿者采集的无药物尿液,分别添加162种不同药物物质,使其浓度达到1000、100、10和1微克/毫升。这些加标样本采用EMIT DAU分析法检测苯丙胺类、巴比妥类、苯二氮卓类代谢物、可卡因代谢物、美沙酮、阿片类药物和丙氧芬。尽管几种检测方法在浓度为100微克/毫升时产生了阳性结果,但许多药物在尿液中可能达不到该浓度。在浓度为100微克/毫升时出现假阳性的药物数量非常少。可卡因代谢物的检测在任何研究浓度下均未产生假阳性结果,而美沙酮的检测产生的假阳性结果数量最多。在解释本调查结果时,必须考虑到在许多情况下尿液中会存在药物代谢物,所研究药物使用的是盐形式,并且离子强度和pH值影响可能会干扰EMIT DAU检测中使用的溶菌酶酶系统。总之,正确利用特异性信息可能有助于分析人员解释在实验室获得的异常值,尤其是当受试者同时使用处方药或非处方药时。